Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. How Reshape Medical built an alternative to bariatric surgery for obesity| DeviceTalks Podcast
In this episode of DeviceTalks, we speak with Richard Thompson, CEO of ReShape Medical, about the company’s bariatric surgery alternative for people suffering from obesity. Read more
2. Mitralign wins FDA nod for tricuspid valve feasibility trial
Mitralign said today that the FDA approved a U.S. feasibility study of its tricuspid valve repair device, under an investigational device exemption. Read more
1. Medtronic says a pair of studies show genetic link to sudden cardiac death
Medtronic (NYSE:MDT) today said 1st-of-a-kind results from a pair of independent clinical trials discovered a gene linked to abnormal heart rhythms that can lead to sudden cardiac death. Read more
The post MassDevice.com +3 | The top 3 medtech stories for August 31, 2015 appeared first on MassDevice.
from MassDevice http://ift.tt/1fRSLpC
Cap comentari:
Publica un comentari a l'entrada